HPV types in Turkey: multicenter hospital based evaluation of 6388 patients in turkish gynecologic oncology group centers
Makaleler > Tam Makale · 2013
Yazarlar: Polat Dursun, Ali Ayhan, Levent Mutlu, Mete Caglar, Ali Haberal, Taygun Gungor, Mustafa Ozat, Emre Ozgu, Anil Onan, Cagatay Taskiran, Haldun Guner, Hakan Yetimalar, Burcu Kasap, Kunter Yuce, M. Coskun Salman, Berkan Sayal, Selen Dogan, Muge Harma, Mehmet Harma, Mustafa Basaran, Huseyin Aydogmus, Yusuf Ergun, Salim Sehirali, Emre Gultekin, Sukran Kose, Yusuf Yildirim, Mufit Yenen, Murat Dede, Ibrahim Alanbay, Riza Karaca, Jale Metindir, Levent Keskin, Isik Ustuner, Filiz Avsar, Hasan Yuksel, Selim Kirdar
Turkish Journal of Pathology, Uluslararası, Scopus, 2013, cilt 29, ss 210-210
DOI: 10.5146/tjpath.2013.01188
Özet
OBJECTIVE: To evaluate the prevalence of HPV DNA and cervical cytological abnormalities, to compare cervical cytology results and HPV DNA and to define HPV types distribution in a large series of Turkish women who have undergone HPV analysis in hospitals that are members of the Turkish Gynecological Oncology Group. MATERIAL AND METHOD: Between 2006 and 2010, a total of 6388 patients' data was retrospectively evaluated at 12 healthcare centers in Turkey. Demographic characteristics, cervical cytology results, HPV status and types were compared. RESULTS: The mean age of the patients was 38.9±10.2. Overall, 25% of the women were found to be HPV positive. Presence of HPV-DNA among patients with abnormal and normal cytology was 52% and 27%, respectively. There was significant difference with respect to decades of life and HPV positivity (p < 0.05). HPV was positive in (within the HPV (+) patients) 37%, 9%, 27%, 20%, 22%, and 41% of the ASCUS, ASC-H, LSIL HSIL, glandular cell abnormalities, and SCC cases respectively The most common HPV types in our study were as follows; HPV 16 (32%), HPV 6 (17%), HPV 11 (9%), HPV 18 (8%), HPV 31 (6%), HPV 51 (5%), HPV 33 (3%). CONCLUSION: In this hospital based retrospective analysis, HPV genotypes in Turkish women with normal and abnormal cytology are similar to those reported from western countries. Further population based prospective multicenter studies are necessary to determine non-hospital based HPV prevalence in Turkish women.